Key result
Anti-EBV T-cell receptor repertoires are broader in multiple sclerosis, demonstrating disease specificity and susceptibility to treatment modulation.
Key points are not available for this paper at this time.
Design
Editorial
This is a scientific commentary on a study investigating the anti-EBV TCR repertoire in multiple sclerosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gavin Giovannoni (2025) studied this question. Anti-EBV T-cell receptor repertoires are broader in multiple sclerosis, demonstrating disease specificity and susceptibility to treatment modulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: